Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$632K Sell
12,059
-1,098
-8% -$58.1K 0.1% 151
2026
Q1
$726K Sell
13,157
-2,242
-15% -$121K 0.13% 130
2025
Q4
$755K Sell
15,399
-3,292
-18% -$154K 0.13% 126
2025
Q3
$807K Sell
18,691
-32,759
-64% -$1.28M 0.14% 119
2025
Q2
$2.01M Sell
51,450
-29,492
-36% -$1.13M 0.39% 60
2025
Q1
$3.14M Buy
80,942
+12,277
+18% +$449K 0.69% 38
2024
Q4
$2.32M Sell
68,665
-15,001
-18% -$540K 0.54% 53
2024
Q3
$3.42M Buy
83,666
+1,482
+2% +$60.6K 0.82% 39
2024
Q2
$3.16M Buy
+82,184
New +$3.46M 0.84% 39

Other funds holding GSK

Drucker Wealth 3.0's GSK Position: Q2 2026 in Review

Drucker Wealth 3.0 reduced its GSK (GSK) stake by 8.3% in Q2 2026, selling an estimated $58.1K and leaving 12,059 shares worth $632K. The position accounts for 0.1% of the portfolio, ranked #151.

Drucker Wealth 3.0 first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.42M in Q3 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Drucker Wealth 3.0 held 12,059 shares of GSK worth $632K as of Q2 2026.
  • Drucker Wealth 3.0 sold 1,098 GSK shares in Q2 2026, an estimated $58.1K.
  • GSK made up 0.1% of Drucker Wealth 3.0's portfolio in Q2 2026, its #151 holding.
  • Drucker Wealth 3.0 first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
  • Drucker Wealth 3.0's GSK position peaked at $3.42M in Q3 2024.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Drucker Wealth 3.0's 13F filing for Q2 2026, filed 13 Jul 2026.